$24.72
+0.13 (+0.53%)
Open$24.45
Previous Close$24.59
Day High$25.02
Day Low$24.13
52W High$30.61
52W Low$8.49
Volume—
Avg Volume1.19M
Market Cap1.81B
P/E Ratio—
EPS$-2.17
SectorBiotechnology
Analyst Ratings
Strong Buy
20 analysts
Price Target
+0.2% upside
Current
$24.72
$24.72
Target
$24.77
$24.77
$14.60
$24.77 avg
$27.54
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 124.49M | 136.25M | 205.11M |
| Net Income | -91,131,037 | -89,764,620 | -12,900,416 |
| Profit Margin | -73.2% | -69.5% | -6.3% |
| EBITDA | -174,644,516 | -181,582,893 | -15,864,221 |
| Free Cash Flow | — | — | -6,278,593 |
| Rev Growth | -8.6% | -8.6% | +24.6% |
| Debt/Equity | 0.19 | 0.19 | 0.13 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.48 | +0.20% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $393.16 | +1.95% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.56 | +0.30% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $510.72 | +0.47% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $798.17 | +1.70% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $244.32 | +1.99% | 40.0 | 32.33B |